AI: For example, advanced diagnostic tests such as CT scans or MRI were more often recommended for high-income patients, ...

The AI models occasionally altered decisions based on patients’ personal characteristics, affecting priority for care and ...

Results of the Phase III HERCULES trial suggest the first potential treatment option for a form of multiple sclerosis.

U.S. Treasury Secretary Scott Bessent said on Wednesday his department will play a greater role in banking regulation to ...

Research reveals that AI models may recommend different treatments based on patients’ socioeconomic and demographic profiles, ...

WEDNESDAY, April 9, 2025 (HealthDay News) -- An experimental drug can help patients with advanced multiple sclerosis (MS) ...

The New England Journal of Medicine (NEJM) published positive results from the HERCULES phase 3 study demonstrating that tolebrutinib delayed disability progression in people with non-relapsing ...

Jerusalem Quartet celebrates 75 years of chamber music in Cleveland Fiery crash raises equipment concerns in Cleveland ...

A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of drugs originally developed to treat lymphomas and related blood disorders, ...

Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosisResults from the HERCULES phase 3 ...

Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called ...